Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients.

by Liad Hinden, Mordechai Avner, Polina Stepensky, Reuven Or, Osnat Almogi-Hazan
Published 2019-01-01